GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 501 - 525 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgM Patient 1 10 moderate
G18057VI
38
IgM Patient 1 10 moderate
G57449OF
38
IgM Patient 1 10 moderate
G63074CQ
38
IgM Patient 1 22 moderate
G00053MO
38
IgM Patient 1 22 moderate
G00066MO
38
IgM Patient 1 22 moderate
G17266GE
38
IgM Patient 1 22 moderate
G19118WX
38
IgG Patient 1 6 moderate
G65889KE
38
IgM Patient 1 6 moderate
G14844CX
38
IgM Patient 1 6 moderate
G17390SF
38
IgM Patient 1 6 moderate
G21320TF
38
IgM Patient 1 6 moderate
G32473MI
38
IgM Patient 1 6 moderate
G40696TO
38
IgM Patient 1 6 moderate
G54064FW
38
IgM Patient 1 6 moderate
G77974XY
38
IgM Patient 1 6 moderate
G99603GB
38
IgG Patient 2 15 mild
G89993FE
38
IgG Patient 2 15 mild
G98068PA
38
IgG Patient 2 24 mild
G89993FE
38
IgG Patient 2 24 mild
G98068PA
38
IgG Patient 2 3 mild
G02670IJ
38
IgG Patient 2 3 mild
G90562PB
38
IgM Patient 2 3 mild
G28868ZC
38
IgG Patient 3 -180 mild
G00053MO
38
IgG Patient 3 -180 mild
G32473MI
38

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024